Table 2.
Prediction performance of CancerSig across 15 cancers
Dataset | miRNA signature | 10-CV accuracy | Sensitivity | Specificity | MCC | AUC | |
---|---|---|---|---|---|---|---|
1 | BLCA | 35 | 84.40 ± 1.27 | 0.64 ± 0.04 | 0.93 ± 0.01 | 0.65 ± 0.02 | 0.82 ± 0.01 |
2 | BRCA | 34 | 80.38 ± 1.55 | 0.79 ± 2.7 | 0.81 ± 2.26 | 0.60 ± 0.03 | 0.81 ± 0.02 |
3 | COAD | 21 | 86.67 ± 2.40 | 0.89 ± 0.02 | 0.82 ± 0.03 | 0.73 ± 0.04 | 0.81 ± 0.02 |
4 | ESCA | 22 | 87.97 ± 2.35 | 0.93 ± 0.02 | 0.78 ± 0.06 | 0.75 ± 0.04 | 0.78 ± 0.03 |
5 | HNSC | 20 | 85.20 ± 1.4 | 0.52 ± 0.06 | 0.95 ± 0.01 | 0.57 ± 0.05 | 0.71 ± 0.03 |
6 | KIRC | 18 | 87.14 ± 1.76 | 0.85 ± 0.02 | 0.87 ± 0.02 | 0.75 ± 0.03 | 0.87 ± 0.01 |
7 | KIRP | 12 | 89.43 ± 2.01 | 0.96 ± 0.01 | 0.73 ± 0.06 | 0.76 ± 0.04 | 0.87 ± 0.03 |
8 | LIHCC | 23 | 89.56 ± 1.27 | 0.94 ± 0.01 | 0.73 ± 0.03 | 0.71 ± 0.03 | 0.86 ± 0.02 |
9 | LUAD | 29 | 74.29 ± 1.33 | 0.80 ± 0.02 | 0.65 ± 0.03 | 0.53 ± 0.02 | 0.7 ± 0.01 |
10 | LUSC | 18 | 79.11 ± 2.28 | 0.74 ± 0.06 | 0.81 ± 0.02 | 0.61 ± 0.03 | 0.80 ± 0.02 |
11 | SKCM | 27 | 78.71 ± 2.47 | 0.79 ± 0.03 | 0.76 ± 0.04 | 0.60 ± 0.03 | 0.75 ± 0.02 |
12 | STAD | 20 | 77.03 ± 1.9 | 0.70 ± 0.03 | 0.79 ± 0.13 | 0.58 ± 0.03 | 0.78 ± 0.03 |
13 | THCA | 26 | 76.37 ± 1.20 | 0.86 ± 0.02 | 0.61 ± 0.04 | 0.55 ± 0.02 | 0.71 ± 0.01 |
14 | READ | 11 | 94.57 ± 2.8 | 0.90 ± 0.05 | 0.97 ± 0.02 | 0.88 ± 0.05 | 0.95 ± 0.03 |
15 | UVM | 13 | 93.33 ± 3.5 | 0.93 ± 0.04 | 0.90 ± 0.13 | 0.86 ± 0.06 | 0.85 ± 0.03 |
Mean ± SD | 21.93 ± 7.30 | 84.27 ± 6.31 | 0.81 ± 0.12 | 0.80 ± 0.10 | 0.67 ± 0.11 | 0.80 ± 0.06 |
10-CV, 10-fold cross-validations; MCC, Matthews correlation coefficient; AUC, area under the ROC curve; SD, standard deviation.